AC
MORF icon

Apogem Capital’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Apogem Capital’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,473
Closed -$259K – 199
2021
Q4 		$259K Buy
5,473
+93
+2% +$4.99K 0.17% 146
2021
Q3 		$305K Buy
5,380
+439
+9% +$26.6K 0.19% 147
2021
Q2 		$284K Buy
+4,941
New +$272K 0.18% 148

Other funds holding MORF

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Apogem Capital's MORF Position: Q1 2022 in Review

Apogem Capital sold out of Morphic Holding, Inc. Common Stock (MORF) in Q1 2022, closing a stake of 5,473 shares — an estimated $259K sold.

Apogem Capital first reported a position in MORF in Q2 2021 and held it in 3 quarters. The position peaked at $305K in Q3 2021. 104 funds tracked by Wall St. Rank hold MORF as of Q1 2022.

  • Apogem Capital reported no remaining Morphic Holding, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Apogem Capital sold 5,473 Morphic Holding, Inc. Common Stock shares in Q1 2022, an estimated $259K.
  • Apogem Capital first reported a position in Morphic Holding, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Apogem Capital's Morphic Holding, Inc. Common Stock position peaked at $305K in Q3 2021.
  • 104 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q1 2022.

Based on Apogem Capital's 13F filing for Q1 2022, filed 16 May 2022.